3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Cervical Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Cisplatin
53
Paclitaxel
27
Carboplatin
22
Brachytherapy
18
Radiotherapy
17
human papillomavirus vaccine, L1 type 16, 18
12
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
12
Gemcitabine
12
Topotecan
8
Vaccines, Synthetic
7
Platinum
7
Papillomavirus Vaccines
7
Radiation
6
Bevacizumab
6
1,2-diaminocyclohexaneplatinum II citrate
6
Neoadjuvant Therapy
5
Chemotherapy, Adjuvant
5
pembrolizumab
4
Vinorelbine
4
Radiotherapy, Intensity-Modulated
4
Pemetrexed
4
Drug Therapy
4
Taxes
3
Surgical Procedures, Operative
3
Ondansetron
3
Irinotecan
3
Dexamethasone
3
Chemoradiotherapy
3
tisotumab vedotin
2
specific substance maruyama
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Uterine Cervical Neoplasms
×
Diphenhydramine
×
Clear all
NCT04237090
2020-10-12
PREMED-F1
Ciusss de L'Est de l'Île de Montréal
Phase 3
Completed
27 enrolled